Abstract
INTRODUCTION
Animal ethics committees are supposed to perform critical cost-benefit evaluations for every single experiment that includes use of non-human animals. But what does this cost-benefit evaluation include? Whose costs and whose benefits are to be compared and evaluated? Many actors and many needs are included in the animal ethics reviews. Science "must" move forward. Patients "must" have better medicines and treatments. Laboratory animals "must" be treated in a responsible way. To understand how the cost-benefit evaluations are really carried out, it is important to look at how the ethical discussions are situated in: 1) the individual members' different interests and interpretations of the mission of animal ethics committees and 2) the meeting context.
Interviews with members of Swedish animal ethics committees show that there are individual interpretations of the mission of the animal ethics committees. In the present article, I will discuss what impact these different views on ethics have on the ethical reviews and how ethics becomes situated in the context of the committee meeting 1 . In what ways do the "outcomes" of the ethical discussions relate to the committee culture, where priorities of interpretation, relations between members, wishes for consensus and expectations built on the past, present and future have strong impact on the outcome of the ethical reviews? Benhabib's concept of situated ethics 2 and theories from the sociology of expectations 3 4 will be used for the analysis.
Background
In Sweden, seven local animal ethics committees examine applications for all non-human animal experiments. Each of the seven committees consists of a chairperson, six scientific experts and six laypersons. The scientific experts come from universities and drug companies.
This category also includes animal technicians and veterinarians. The laypersons represent local political parties or animal welfare organizations 5 . In the committees you can find future Nobel Prize candidates, people who have never seen a laboratory and animal rights activists.
They are actors with dissimilar agendas and different backgrounds, and one can easily imagine how this committee composition could stimulate lively discussions and conflict situations at the meetings -and perhaps also rejection of applications. Despite this, in 2003, 1733 cases were handled, and 99 percent of all applications were approved -sometimes with requested modifications 6 . Only 22 cases were rejected 7 .
The committees' task is to make cost-benefit evaluations. Is the animals' suffering counterbalanced by the expected benefits of the research? The committees are also supposed to discuss every single application on the basis of The Three Rs: Refinement, Reduction and Replacement 8 9 10 . These people focus the animal in their ethical evaluation; they imply that this is what should be discussed at the committee meetings. Sofia (AR) also focuses on the animals.
METHOD

"My basic opinion is that animals have rights, and one of these rights is to not suffer. And almost every animal experiment causes some suffering, and it is just for our -human beings' -benefit that all animal experiments are done. I/---/ So what I do in the committee is just fix the surface and improve the animals' existence" (Sofia, AR.).
Ethics in the name of the animal can be articulated in different ways. John, Maria and Pia talk about this category of ethics on a very practical level. As does Sofia, but she also wishes to raise questions to a theoretical level -do human beings have the right to use other animals for their own well-being? However, as there is no scope for animal rights arguments in the committee meetings, she focuses on animal welfare instead of animal rights. No one besides other animal rights spokespeople consider these types of arguments to be relevant. Animal welfare issues, on the other hand, are in focus most of the time. But not everyone considers animal welfare to be the main aim of the discussions. Ethics can also be discussed in the name of science.
In the name of Science
Ethics in the name of science is here expressed by two prominent researchers. To them, it is important to be part of the committee, because then they are able to empower scientific research. This view concerns opportunities for science to evolve. It becomes unethical not to use nonhuman animal experimentation in research 13 . Both these men define themselves as basic researchers. They do not apply their research to patients; their primary concern is the science itself. They also highlight the enemies of research -the representatives of animal rights or animal welfare movements. These persons are defined as obstacles, their aim being to stop scientific progress and destroy the hopes and expectations of many severely ill people who are dependent on animal experiments. This leads us to the next category.
In the name of Patients
Marianne has worked as a medical doctor. No purpose is a bad enough to be rejected. The idea that the purpose of the research should be evaluated in relation to the suffering of animals is very seldom put into practice. The scientific experts agree that research is (almost) always necessary -in the name of science or in the name of the patients. The rhetoric varies, but the content is the same. It is not unethical to use animals in research. It is unethical not to do so.
Cost-benefit evaluations?
The notion that animal ethics committees should be evaluating the relation between suffering evaluate. Therefore there is a risk that just one view will be expressed in the meetings. On the other hand, this variation could be a fantastic opportunity; the committee members can point out different ethical aspects at the meeting and contribute to an important discussion about costs and benefits, which is the very idea behind the committees' composition 18 . But how does the discussion unfold in the meetings? Are there any multi-faceted cost-benefit evaluations?
"We are only discussing questions about details. /---/ I would like to discuss more about the purpose of the experiment" (Sofia, AR). "A lot of what we are discussing -someone has even claimed that 99% of what we are discussingisn't ethics, it is something else" (Anders, SE).
Most of the interviewees agree that the animal ethic committees are discussing the "wrong" questions. They all know that they are supposed to be conducting cost-benefit evaluations, but they are instead discussing experimental methodology. discussions often are centred on technical issues. In Sweden, half of the committees consist of laypersons, and the discussions still focus on methodological and technical issues. I will suggest a few other explanations for this reduced ethical review.
Priority of interpretation
One reason why mostly technical issues are on the committees' agenda may concern whoand what discourse -has the priority of interpretation in this context. Even if the scientific experts are not in the majority, they have power over the agenda. Observations from the committee meetings show that the priority of interpretation belongs -exclusively -to scientific ideals. There is no room for ethical questions about research purposes and animal suffering in this context. This becomes an unspoken issue, even though members agree that this is their mission.
The discourse used in the discussions is scientific, and the ethical issues discussed are related to the experiment itself. Representatives of animal welfare and animal rights organizations have often adopted this discourse, and talk about minimizing suffering from a scientific point of view. They have often read scientific journals, are informed about new -more humane -technical solutions and talk about animal experimentation in scientific terms. Using this strategy, they are included in the discussion, and listened to. When they try to raise questions about animal rights, they are considered radical activists and therefore easily dismissed.
The community members' mission is to serve as an interface between the public and the research institutions, and raising ethical questions 25 26 is difficult to carry through.
Attitude surveys also show that the public is concerned about ethics, safety and value in relation to using non-human animals in research 27 . But in the committee discussions, the public representations view is limited to a patient-oriented desire for biomedical solutions.
This priority of interpretation prevents a discussion including animal concerns issues and worries of the public. Instead, the scientific experts confront the lay people with "the best solution" 28 29 .
Consensus
Another reason why mainly technical problems are discussed is that, on these issues, members can reach a consensus. Moreno 30 shows the importance of consensus in the culture of bioethics. As we have seen, it may be difficult for members to reach a consensus if the research purpose is -or is not -good enough to justify animal suffering. The cost-benefit evaluation becomes too complex in a context where consensus is supposed to be reachedand therefore it becomes a non-issue in the committee. But one theme all members can agree on is how to minimize the suffering of animals. Solutions can be found in relation to the most technical aspects, at least they can agree on a humane end-point, when the animal will be put to death. Better technical solutions benefit scientific research as well as the animals. They probably also benefit patients. Decreasing suffering can be done in the name of science, in the name of patients and in the name of animals.
In the committee meetings, there can also be a consensus surrounding hope.
Those who cannot understand the magic and greatness of scientific progress are seen as fundamentalists -in this case "animal rights activists". The social construction of "The
Other" in debates on biotechnologies is a strong force in strategies used to reach a consensus about the "right" decision 31 .
Expectations
The hegemonic social discourse is that biotechnology, including for example use of transgenic animals and embryonic stem cell research, is the modern salvation -the hope for humanity. In the public discourse, biotechnologies are almost synonymous with the language and imagery of futuristic breakthroughs 32 . In this discourse, medical reason is always a good enough reason to use animals as well as embryos for health purposes. The hope of biotechnological salvation shadows concerns about experimental animals. The expectations of technology are performative, because they mobilize the future into the present using mutually binding promises and agendas, often articulated as "progress" or "the good life" 33 .
At the same time, the scientific experts, who have the priority of interpretation, use historical narratives, in which animal rights activists are able to stop scientific breakthroughs. Thus, ethics is not only situated in the context of the committee meeting, but, as Brown writes, also temporally situated in "relation to memories of past futures and future presents" 34 . Narratives about history and the future have a strong influence on the ethics of the present. The discursive fear of historical animal rights activism, and the hopeless future that would follow in its tracks, shadows opportunities to question animal experimentation from any point of view.
CONCLUSIONS
Members of the Swedish animal ethics committees agree that they are supposed to perform cost-benefit evaluations and scrutinize research aims in relation to animal suffering. But the individual interpretations of why they are doing this, and in whose name, differ. Ethical reviews can be made in the name of science, patients and animals. This intersection of different views could be an interesting foundation for complex cost-benefit evaluations, but in the meetings, the discussions focus on technical and methodological improvements instead of on weighing research aims against animal suffering.
This reduced ethical evaluation can be understood from the perspective of situated ethics. The ethics is situated in the context of the committee meeting and the relations between committee members. The committee culture is strongly characterized by a scientific priority of interpretation and a desire for consensus. The discussions on use of animals are also situated in the future and in the past; in the hopes for scientific progress, medical solutions, but also in narratives about the historical threats posed by animal rights activists. A more open discussion climate and a focus on present research could build a better foundation for real cost-benefit evaluations, and offer better possibilities for committee members to fulfil their mission.
